GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » ROE % Adjusted to Book Value

Modern Chinese Medicine Group Co (HKSE:01643) ROE % Adjusted to Book Value : -6.02% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co ROE % Adjusted to Book Value?

Modern Chinese Medicine Group Co's ROE % for the quarter that ended in Jun. 2024 was -2.89%. Modern Chinese Medicine Group Co's PB Ratio for the quarter that ended in Jun. 2024 was 0.48. Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -6.02%.


Modern Chinese Medicine Group Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modern Chinese Medicine Group Co ROE % Adjusted to Book Value Chart

Modern Chinese Medicine Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - 28.88 31.66 27.67 4.55

Modern Chinese Medicine Group Co Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.39 21.14 23.49 -6.02 15.73

Competitive Comparison of Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value falls into.


;
;

Modern Chinese Medicine Group Co ROE % Adjusted to Book Value Calculation

Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.79% / 0.39
=27.67%

Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-2.89% / 0.48
=-6.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modern Chinese Medicine Group Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Modern Chinese Medicine Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills among others. Geographically, the company derives its key revenue from the People's Republic of China.
Executives
Sun Xinlei 2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si 2101 Beneficial owner
Xie Wei 2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co Headlines

No Headlines